POTS in NYC: An Integrative Medicine Approach to Postural Orthostatic Tachycardia Syndrome
Postural Orthostatic Tachycardia Syndrome, or POTS, is a form of dysautonomia—dysfunction of the autonomic nervous system—characterized by an abnormal increase in heart rate upon moving from lying to standing, accompanied by a constellation of symptoms that can be profoundly disabling. Despite affecting an estimated 1-3 million Americans, POTS remains underdiagnosed and undertreated in conventional medical settings.
For patients in New York City seeking a more comprehensive approach, RHPNY offers an integrative framework that goes beyond symptom management to address potential root causes and improve quality of life.
What Is POTS?
POTS is defined clinically by a heart rate increase of 30+ beats per minute within 10 minutes of standing (40+ in patients under 19), in the absence of orthostatic hypotension. The heart rate increase is a compensatory mechanism—the autonomic nervous system attempting to maintain blood pressure when venous return to the heart is impaired.
Common Symptoms of POTS
- Lightheadedness or presyncope upon standing
- Heart palpitations and tachycardia
- Extreme fatigue—often disproportionate to activity
- Brain fog and cognitive difficulties ("brain fog")
- Exercise intolerance
- Headache (often positional)
- Nausea and GI disturbances
- Temperature regulation problems
- Sleep disturbances
- Tremors and shakiness
The severity of POTS varies widely. Some patients have mild symptoms; others are housebound or wheelchair-dependent at their worst.
Who Gets POTS?
POTS disproportionately affects young women (approximately 80% of POTS patients are female, most between ages 15-50). Post-viral POTS—triggered by viral illness, including COVID-19, Epstein-Barr virus, and other infections—has been increasingly recognized. Autoimmune mechanisms, mast cell activation, hypermobility syndromes (particularly Ehlers-Danlos syndrome), and connective tissue disorders are commonly associated.
The post-COVID surge in POTS diagnoses has brought significant new research attention to the condition, accelerating understanding of potential mechanisms.
Why Conventional Treatment Often Falls Short
Standard POTS management focuses on:
- Increased salt and fluid intake
- Compression garments
- Beta-blockers (propranolol, atenolol) or ivabradine to reduce heart rate
- Fludrocortisone to expand blood volume
- Physical reconditioning protocols
These approaches help many patients but fail to address underlying mechanisms. For patients with autoimmune POTS, mast cell involvement, or post-viral neuroinflammation, symptom management alone provides incomplete relief.
An Integrative Approach to POTS at RHPNY
At Regen Health Physicians NYC, Dr. Ajit Dhaliwal approaches POTS as a systemic condition with potentially modifiable root causes. The integrative evaluation includes:
Identifying Underlying Mechanisms
- Autoimmune markers: Anti-ganglionic acetylcholine receptor antibodies, anti-adrenergic receptor antibodies, and broader autoimmune panels
- Mast cell activation assessment: Serum tryptase, 24-hour urine histamine and prostaglandins, clinical pattern evaluation
- Connective tissue assessment: Beighton score, skin fragility, joint hypermobility
- Mitochondrial and metabolic function: CoQ10 levels, B12, folate, iron studies, comprehensive metabolic panel
- Hormonal evaluation: Cortisol rhythm (adrenal function), thyroid panel, sex hormone assessment
- Gut microbiome and intestinal permeability: Emerging research implicates gut dysbiosis in dysautonomia
Therapeutic Strategies Beyond Conventional Management
[Peptide therapy](/peptides): Selected peptides may support autonomic nervous system regulation and reduce neuroinflammation. BPC-157 has demonstrated autonomic-modulating effects in preclinical models. Thymosin Alpha-1 may help modulate the immune response in autoimmune POTS.
[Chronic disease management](/chronic-disease): For patients with mast cell activation syndrome (MCAS) driving POTS symptoms, targeted mast cell stabilization (cromolyn, ketotifen, quercetin, luteolin) combined with low-histamine dietary intervention can produce dramatic improvement.
Mitochondrial support: CoQ10, NAD+ precursors, and alpha-lipoic acid support energy metabolism at the cellular level—addressing the fatigue component of POTS that autonomic interventions alone cannot reach.
Nervous system rehabilitation: Structured exercise reconditioning (starting supine or semi-recumbent to avoid orthostatic stress) combined with heart rate variability training builds autonomic flexibility over time.
Managing Flares and Improving Daily Function
RHPNY works with POTS patients on practical strategies to manage flares, understand triggers, and gradually expand activity tolerance. The goal is not simply reducing heart rate numbers—it's restoring quality of life.
Schedule a consultation at RHPNY to discuss an integrative evaluation of POTS or other dysautonomia symptoms in New York City or Salt Lake City.
--- This article is for informational purposes only and does not constitute medical advice. POTS management should be individualized based on clinical assessment by a qualified physician.
